Bismuth chelation for targeted alpha therapy: Current state of the art
Article in Nuclear Medicine and Biology (June 2022)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
Recent Achievements about Targeted Alpha Therapy-Based Targeting Vectors and Chelating Agents
Article in Anti-Cancer Agents in Medicinal Chemistry (January 2022)
Chelating the Alpha Therapy Radionuclides 225Ac3+ and 213Bi3+ with 18-Membered Macrocyclic Ligands Macrodipa and Py-Macrodipa
Article in Inorganic Chemistry (December 2021)